James E. Dalen

26.7k total citations · 8 hit papers
204 papers, 18.4k citations indexed

About

James E. Dalen is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, James E. Dalen has authored 204 papers receiving a total of 18.4k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Cardiology and Cardiovascular Medicine, 73 papers in Internal Medicine and 39 papers in Surgery. Recurrent topics in James E. Dalen's work include Venous Thromboembolism Diagnosis and Management (73 papers), Atrial Fibrillation Management and Outcomes (44 papers) and Acute Myocardial Infarction Research (39 papers). James E. Dalen is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (73 papers), Atrial Fibrillation Management and Outcomes (44 papers) and Acute Myocardial Infarction Research (39 papers). James E. Dalen collaborates with scholars based in United States, Canada and Switzerland. James E. Dalen's co-authors include Joseph S. Alpert, Jack Hirsh, Daniel Deykin, Robert J. Goldberg, L. Poller, Joel M. Gore, Henry I. Bussey, Robert Raschke, E. Magnus Ohman and Christopher B. Granger and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

James E. Dalen

203 papers receiving 17.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

1987 1.8k citations James E. Dalen et al. Circulation profile →
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range

2001 1.2k citations James E. Dalen, Henry I. Bussey et al. CHEST Journal profile →
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety

2001 1.2k citations Jack Hirsh, James E. Dalen et al. CHEST Journal profile →
Heparin and Low-Molecular-Weight Heparin

1998 817 citations Jack Hirsh, James E. Dalen et al. CHEST Journal profile →
Natural history of pulmonary embolism

1975 815 citations James E. Dalen, Joseph S. Alpert Progress in Cardiovascular Diseases profile →
Platelet-Active Drugs

2001 717 citations Carlo Patrono, Barry S. Coller et al. CHEST Journal profile →
Antithrombotic Therapy in Atrial Fibrillation

2008 569 citations Gregory W. Albers, James E. Dalen et al. CHEST Journal profile →
Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety

1992 435 citations Jack Hirsh, James E. Dalen et al. CHEST Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James E. Dalen United States	63	11.9k	6.6k	5.3k	2.1k	2.1k	204	18.4k
Basil S. Lewis Israel	52	20.1k 1.7×	6.9k 1.1×	8.6k 1.6×	2.7k 1.3×	2.9k 1.4×	278	28.0k
Gilles Montalescot France	80	23.1k 2.0×	5.8k 0.9×	12.3k 2.3×	2.7k 1.3×	1.4k 0.7×	553	28.8k
A. Michael Lincoff United States	92	20.8k 1.8×	5.5k 0.8×	14.0k 2.7×	2.7k 1.3×	1.5k 0.7×	418	31.1k
Pierre Théroux Canada	74	19.0k 1.6×	3.1k 0.5×	10.2k 1.9×	1.2k 0.5×	1.2k 0.6×	273	26.4k
Gary E. Raskob United States	58	11.1k 0.9×	13.3k 2.0×	4.8k 0.9×	2.9k 1.4×	1.8k 0.9×	170	19.6k
Philip S. Wells Canada	63	10.4k 0.9×	14.9k 2.3×	5.6k 1.1×	1.5k 0.7×	2.0k 0.9×	299	19.7k
Michael Gent Canada	90	20.2k 1.7×	16.1k 2.5×	9.1k 1.7×	4.3k 2.0×	5.7k 2.7×	230	34.9k
Maarten L. Simoons Netherlands	77	22.8k 1.9×	2.5k 0.4×	9.8k 1.9×	2.0k 0.9×	2.9k 1.4×	355	29.8k
Stavros Konstantinides Germany	68	9.4k 0.8×	11.4k 1.7×	2.7k 0.5×	2.8k 1.3×	4.7k 2.3×	452	18.3k
Jean‐Pierre Bassand France	46	10.7k 0.9×	2.9k 0.4×	3.8k 0.7×	1.1k 0.5×	1.2k 0.6×	176	13.5k

Countries citing papers authored by James E. Dalen

Since Specialization

Citations

This map shows the geographic impact of James E. Dalen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Dalen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Dalen more than expected).

Fields of papers citing papers by James E. Dalen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Dalen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Dalen. The network helps show where James E. Dalen may publish in the future.

Co-authorship network of co-authors of James E. Dalen

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Dalen. A scholar is included among the top collaborators of James E. Dalen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Dalen. James E. Dalen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dalen, James E. & Joseph S. Alpert. (2016). Silent Atrial Fibrillation and Cryptogenic Strokes. The American Journal of Medicine. 130(3). 264–267. 17 indexed citations

Goldberg, Robert J., Frederick A. Spencer, Jorge Yarzebski, et al.. (2004). A 25-year perspective into the changing landscape of patients hospitalized with acute myocardial infarction (the Worcester Heart Attack Study). The American Journal of Cardiology. 94(11). 1373–1378. 74 indexed citations

Dalen, James E., et al.. (2003). Clinicians' Responses to Direct-to-Consumer Advertising of Prescription Medications. Archives of Internal Medicine. 163(15). 1808–1808. 33 indexed citations

Dalen, James E.. (2002). Does Anticoagulant Therapy Reduce Mortality of Acute Pulmonary Embolism?—Reply. JAMA Internal Medicine. 162(6). 720–720. 1 indexed citations

Stein, Paul D., Joseph S. Alpert, Henry I. Bussey, James E. Dalen, & Alexander G.G. Turpie. (2001). Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves. CHEST Journal. 119(1). 220S–227S. 288 indexed citations

Dalen, James E. & P. Zoē Stavri. (2000). A Second Century for the Archives of Internal Medicine. Archives of Internal Medicine. 160(1). 15–15. 1 indexed citations

Patrono, Carlo, Barry S. Coller, James E. Dalen, et al.. (1998). The Relationships Among Dose, Effectiveness, and Side Effects. CHEST Journal. 114(5). 17 indexed citations

Laupacis, Andreas, Gregory W. Albers, James E. Dalen, et al.. (1995). Antithrombotic Therapy in Atrial Fibrillation. CHEST Journal. 108(4). 352S–359S. 156 indexed citations

Goldberg, Robert J., Edward J. Gorak, Jorge Yarzebski, et al.. (1993). A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease.. Circulation. 87(6). 1947–1953. 201 indexed citations

10.

Dalen, James E. & Robert J. Goldberg. (1992). Prophylactic Aspirin and the Elderly Population. Clinics in Geriatric Medicine. 8(1). 119–126. 5 indexed citations

11.

Hirsh, Jack, et al.. (1992). Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety. CHEST Journal. 102(4). 337S–351S. 435 indexed citations breakdown →

12.

Goldberg, Robert J., et al.. (1992). Prognosis of acute myocardial infarction complicated by complete heart block (the Worcester heart attack study). The American Journal of Cardiology. 69(14). 1135–1141. 69 indexed citations

13.

Dalen, James E.. (1990). Valvular heart disease, infected valves and prosthetic heart valves. The American Journal of Cardiology. 65(6). C29–C31. 7 indexed citations

14.

Goldberg, Robert J., Joel M. Gore, Jerry H. Gurwitz, et al.. (1990). The Impact of Age on the Incidence and Prognosis of Initial Acute Myocardial Infarction. Survey of Anesthesiology. 34(1). 45–45. 1 indexed citations

15.

Goldberg, Robert J., Joel M. Gore, Joseph S. Alpert, & James E. Dalen. (1989). Declining incidence and case fatality rates of acute myocardial infarction in a community-wide study. 6(2). 98–113. 1 indexed citations

16.

Hirsh, Jack, et al.. (1989). Aspirin and Other Platelet Active Drugs. CHEST Journal. 95(2). 12S–18S. 5 indexed citations

17.

Dalen, James E. & Joseph S. Alpert. (1975). Natural history of pulmonary embolism. Progress in Cardiovascular Diseases. 17(4). 259–270. 815 indexed citations breakdown →

18.

Dalen, James E., Joseph S. Alpert, Lawrence H. Cohn, Harrison Black, & John J. Collins. (1974). Dissection of thoracic aorta: Medical or surgical therapy?. The American Journal of Cardiology. 33(1). 133–133. 5 indexed citations

19.

Johnson, Lewis W., William Grossman, James E. Dalen, & Lewis Dexter. (1972). Pulmonic Stenosis in the Adult. New England Journal of Medicine. 287(23). 1159–1163. 29 indexed citations

20.

Gazzaniga, Alan B. & James E. Dalen. (1970). PARADOXICAL EMBOLISM. Obstetrical & Gynecological Survey. 25(7). 669–671. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact